Leukemia; Head & Neck Cancer; Immunotherapy; Vaccines; Lung Cancer; Melanoma; Bladder Cancer; Breast Cancer; Throat Cancer; Aetiology; Pancreatic Cancer

Latest news and research on all cancers and treatments, updated several times a week

Click here to Survive Longer        Here for Anti-Cancer Program          My Story starts HERE

Here’s a Sample of My Raw Data -> In Excel -> Leaner (Excel) -> with dictionary

Click here to see how I do my statistical analyses

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy ...

Cancer Research UK, Cancer Research Technology (CRT) and Amgen have reached an agreement to take forward Amgen's experimental ...

CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck CancerTrial with Addition of ...

Vienna, VA -- (ReleaseWire) -- 12/23/2014 -- CEL-SCI Corporation announced that during November it has added seven new clinical sites to its global ...

FDA approves Bristol-Myers's skin cancer treatment Opdivo

s Opdivo for advanced skin cancer, the latest drug to reach the market in the emerging field of cancer immunotherapy. The decision by the Food and ...

FDA Gives Green Signal To Bristol-Myers Squibb Co's (BMY) Skin Cancer Drug Opdivo - Bidness ETC

With Opdivo approval, Bristol-Myers arms for PD-1 battle against Merck's Keytruda - FiercePharma

Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle in the ...

The grant award will assist with advancing an SVP cancer immunotherapy from preclinical through early clinical evaluation. This immuno-oncology ...

Stock in Focus: NewLink Genetics Corp (NASDAQ:NLNK)

It is also developing HyperAcute Lung immunotherapy for non-small cell lung cancer; HyperAcute Melanoma immunotherapy for the treatment of ...

Ebola crisis pushes NewLink into limelight - Macro Insider

Theralase (V.TLT) celebrates positive test results from revolutionary bladder cancer treatment

Theralase Technologies (TSX: V.TLT, Stock Forum) had reason to break out the champagne today when the company announced preliminary results ...

Theralase Reports Results of PDC Therapy of Bladder Cancer in Orthotopic Rat Model - MarketWatch

Genetic Polymorphism As A Diagnostic Predictor For NSCLC Patients

... T393C polymorphism and prognosis in several types of cancer, including breast carcinoma, squamous cell carcinoma of the larynx, bladder cancer, ...

  

Cancer News in Science Daily

Whole-genome sequencing can successfully identify cancer-related mutations

Whole-genome sequencing can be used to identify patients' risk for hereditary cancer, researchers have demonstrated. This is the first study that has used whole-genome sequencing to evaluate a series of 258 cancer patients' genomes to improve the ability to diagnose cancer-predisposing mutations, researchers say.

Mechanics of cells' long-range communication modeled by researchers

Interdisciplinary research is showing how cells interact over long distances within fibrous tissue, like that associated with many diseases of the liver, lungs and other organs. By developing mathematical models of how the collagen matrix that connects cells in tissue stiffens, the researchers are providing insights into the pathology of fibrosis, cirrhosis of the liver and certain cancers.

Armed virus shows promise as treatment for pancreatic cancer

A new combination of two different approaches -- virotherapy and immunotherapy -- is showing 'great promise' as a treatment for pancreatic cancer, according to new research. The study investigated whether the effectiveness of the Vaccinia oncolytic virus -- a virus modified to selectively infect and kill cancer cells -- as a treatment for pancreatic cancer, would be improved by arming it with a gene which modulates the body's immune system.

Test predicts response to treatment for complication of leukemia stem cell treatment

A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life-threatening complication of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study.